Perspective Therapeutics Q2 2025 Earnings Preview

1 hour ago 1

Perspective Therapeutics (NYSE:CATX) is scheduled to announce Q2 earnings results on Wednesday, August 13th, before market open.
The consensus EPS Estimate is -$0.29 and the consensus Revenue Estimate is $0.17M (-67.9% Y/Y).
Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 1 downward.

Recommended For You